Munmun M. Rahman

Izumo, 6938501, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.

Journal: International journal of oncology
Published: October 06, 2015

Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.

Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.

Journal: Oncology letters
Published: September 23, 2015

ESR1 gene amplification in endometrial carcinomas: a clinicopathological analysis.

ESR1 gene amplification in endometrial carcinomas: a clinicopathological analysis.

Journal: Anticancer research
Published: September 12, 2013

A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies.

A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies.

Journal: International journal of molecular sciences
Published: February 17, 2013

KRAS and MAPK1 gene amplification in type II ovarian carcinomas.

KRAS and MAPK1 gene amplification in type II ovarian carcinomas.

Journal: International journal of molecular sciences
Published: February 01, 2013

PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.

PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.

Journal: Anticancer research
Published: December 26, 2012

Is ATP7B a predictive marker in patients with ovarian carcinoma treated with platinum-taxane combination chemotherapy?

Is ATP7B a predictive marker in patients with ovarian carcinoma treated with platinum-taxane combination chemotherapy?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 11, 2012

Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.

Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.

Journal: American journal of clinical pathology
Published: September 27, 2012

NAC1, a BTB/POZ protein overexpressed in uterine sarcomas.

NAC1, a BTB/POZ protein overexpressed in uterine sarcomas.

Journal: Anticancer research
Published: September 21, 2012

Gene amplification of ZNF217 located at chr20q13.2 is associated with lymph node metastasis in ovarian clear cell carcinoma.

Gene amplification of ZNF217 located at chr20q13.2 is associated with lymph node metastasis in ovarian clear cell carcinoma.

Journal: Anticancer research
Published: July 31, 2012

Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.

Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.

Journal: Oncology
Published: May 18, 2012

Significance of the concentration of chelating ligands on Fe3+-solubility, bioavailability, and uptake in rice plant.

Significance of the concentration of chelating ligands on Fe3+-solubility, bioavailability, and uptake in rice plant.

Journal: Plant physiology and biochemistry : PPB
Published: May 11, 2012
Showing 1-12 of 20

Last Updated: 09/26/2026